Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

22.99

-0.37 (-1.58%)

At close: Jun 12, 2026, 4:00 PM EDT

22.59

-0.40 (-1.74%)

After-hours: Jun 12, 2026, 6:52 PM EDT

Pacira BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	905	1,064	871	1,568	1,773	2,692
Market Cap Growth	-24.66%	22.15%	-44.45%	-11.56%	-34.12%	3.08%
Enterprise Value	1,114	1,244	1,025	1,876	2,248	3,164
Last Close Price	22.99	25.88	18.84	33.74	38.61	60.17
PE Ratio	192.91	161.75	-	37.91	113.56	65.40
Forward PE	7.45	7.53	7.10	10.23	11.64	15.43
PEG Ratio	-	0.54	0.54	0.54	0.66	0.66
PS Ratio	1.23	1.46	1.24	2.32	2.66	4.97
PB Ratio	1.38	1.54	1.12	1.80	2.29	3.69
P/FCF Ratio	6.82	-	4.87	11.24	15.39	33.71
P/OCF Ratio	6.36	-	4.60	10.14	12.21	21.41
EV/Sales Ratio	1.52	1.71	1.46	2.78	3.37	5.84
EV/EBITDA Ratio	9.18	64.82	189.40	11.49	14.84	26.71
EV/EBIT Ratio	36.99	64.82	-	21.39	37.45	35.19
EV/FCF Ratio	8.39	-	5.74	13.45	19.51	39.63
Debt / Equity Ratio	0.61	0.59	0.55	0.65	0.93	1.02
Debt / EBITDA Ratio	17.06	21.79	118.00	3.59	5.04	9.53
Debt / FCF Ratio	-	-	3.57	4.20	6.63	14.14
Net Debt / Equity Ratio	0.32	0.26	0.20	0.35	0.61	0.65
Net Debt / EBITDA Ratio	8.67	9.37	28.49	1.88	3.13	3.99
Net Debt / FCF Ratio	-	-	0.86	2.20	4.12	5.92
Asset Turnover	0.59	0.52	0.45	0.41	0.36	0.32
Inventory Turnover	1.00	1.08	1.48	1.84	2.05	1.72
Quick Ratio	3.01	3.01	1.93	3.94	2.62	1.44
Current Ratio	4.73	4.54	2.40	5.24	3.37	1.66
Return on Equity (ROE)	0.76%	0.96%	-12.08%	5.10%	2.11%	6.22%
Return on Assets (ROA)	0.76%	0.57%	-7.40%	3.66%	3.82%	4.00%
Return on Invested Capital (ROIC)	1.03%	0.83%	-10.36%	4.76%	4.99%	5.61%
Return on Capital Employed (ROCE)	2.15%	1.61%	-5.39%	5.82%	3.89%	6.98%
Earnings Yield	0.57%	0.62%	-	2.64%	0.88%	1.53%
FCF Yield	14.67%	0.00%	20.52%	8.89%	6.50%	2.97%
Buyback Yield / Dilution	5.52%	2.60%	11.03%	-11.69%	-1.99%	-4.46%
Total Shareholder Return	5.52%	2.60%	11.03%	-11.69%	-1.99%	-4.46%

SEC Filings: 10-K · 10-Q